Carl-Johan Dalsgaard
Chief Executive Officer at BioFactor Therapeutics AB
Net worth: 656 225 $ as of 30/03/2024
Profile
Carl-Johan Dalsgaard founded RSPR Pharma AB, where he worked as Chief Executive Officer.
Dr. Dalsgaard also currently works at CePeP AB, as Chief Executive Officer, Vicore Pharma AB, as Chief Executive Officer & Director, BioCrine AB, as Chief Executive Officer, BioFactor Therapeutics AB, as Chief Executive Officer, Healthcap IV GP AB, as Member, HealthCap AB, as Partner from 2000, and Healthcap IV GP SA, as Member.
Dr. Dalsgaard also formerly worked at Biolipox AB, as Chief Executive Officer, LTB4 Sweden AB, as Chief Executive Officer, Vicore Pharma Holding AB, as Chief Executive Officer from 2018 to 2023, Astra Pain Control AB, as Chief Executive Officer, INIM Pharma AB, as Chief Executive Officer & Director, Tengion, Inc., as Director from 2004 to 2011, Affibody AB, as Director, AstraZeneca AB, as Director-Preclinical Research, Karolinska Institutet Innovations AB, as Managing Director, Astra AB, as Vice President & Head-Therapy, and Odlander, Fredrikson & Co. AB, as Principal.
Dr. Dalsgaard received his doctorate degree from Karolinska Institutet and doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VICORE PHARMA HOLDING AB
0.43% | 29/06/2023 | 477,981 ( 0.43% ) | 656 225 $ | 30/03/2024 |
Carl-Johan Dalsgaard active positions
| Companies | Position | Start |
|---|---|---|
| BioFactor Therapeutics AB | Chief Executive Officer | 13/08/2009 |
CePeP AB
 CePeP AB Miscellaneous Commercial ServicesCommercial Services CePeP AB provides pharmaceutical research and development services. Its cell penetrating peptides are used for treatment of cancer and endocrine disorders. The company was founded in November 2001 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | 13/08/2009 |
| BioCrine AB | Chief Executive Officer | 13/08/2009 |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Private Equity Investor | 02/08/2010 |
| Healthcap IV GP SA | Corporate Officer/Principal | - |
Healthcap IV GP AB
 Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The private company is based in Sundsvall, Sweden. | Corporate Officer/Principal | - |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Chief Executive Officer | - |
Former positions of Carl-Johan Dalsgaard
| Companies | Position | End |
|---|---|---|
| VICORE PHARMA HOLDING AB | Chief Executive Officer | 08/09/2023 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | President | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Carl-Johan Dalsgaard
| Karolinska Institutet | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TENGION, INC. | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| Private companies | 17 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Healthcap IV GP AB
Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The private company is based in Sundsvall, Sweden. | Finance |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Finance |
Odlander, Fredrikson & Co. AB
 Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Finance |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
CePeP AB
CePeP AB Miscellaneous Commercial ServicesCommercial Services CePeP AB provides pharmaceutical research and development services. Its cell penetrating peptides are used for treatment of cancer and endocrine disorders. The company was founded in November 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
| BioCrine AB | |
| Healthcap IV GP SA | |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology RSPR Pharma AB develops therapeutics for inflammatory vascular diseases. The firm's products are used to treat diseases such as atherosclerosis and abdominal aortic aneurysm. The company was founded by Carl-Johan Dalsgaard in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
| BioFactor Therapeutics AB | |
LTB4 Sweden AB
 LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Health Technology |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
| Astra Pain Control AB | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Carl-Johan Dalsgaard
